Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
about
Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway.Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.The 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.P53-derived hybrid peptides induce apoptosis of synovial fibroblasts in the rheumatoid joint.Deficiency of protein-L-isoaspartate (D-aspartate) O-methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma.Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer.B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
P2860
Q37355325-A8F464C5-0408-460A-BD27-0D8964622D79Q37748056-98A17BF4-1861-4CCB-BC6E-E2DFE6A64FA0Q41810049-4C2A9E9F-2980-4A6A-891B-5FC60BD761C4Q42700916-F669527E-8EC3-439E-917D-EE26633CE8D0Q44744253-ACD0E605-4DD0-461B-9EA0-C25B4BBEF257Q46941249-434D2985-7024-465E-A6DC-9C3241B766D8Q47106228-9354A639-9BBD-4C2D-A84B-7CE990A6FB0DQ47212945-F1DECA2A-C098-485D-AFEB-6DDCC84DD2C8Q48518814-211B64B0-FB2D-4D34-A0F9-8D392F6CF8F0Q52641589-C5E8ADD2-80EB-44F2-BD6A-C03222D6E5ABQ55099981-25E5E7A1-EBBF-473D-B0E6-CA2AA2F2B58AQ55375930-20F09BCD-6ECB-420F-9EDB-7F023A31DC70Q57176931-5B9E508E-335C-47A9-8E4D-3A13835AD706
P2860
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@ast
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@en
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@nl
type
label
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@ast
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@en
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@nl
prefLabel
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@ast
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@en
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Reactivating p53 functions by ...... tunity in p53 wild-type tumors
@en
P2093
Hidemichi Watari
Junichi Hamada
Masataka Kudo
Masayoshi Hosaka
Noriaki Sakuragi
Sharon J B Hanley
Takahiro Yamada
P2860
P304
19968-19975
P3181
P356
10.18632/ONCOTARGET.4847
P407
P50
P5008
P577
2015-08-01T00:00:00Z